Propanc Biopharma, Inc. (PPCB)
OTCMKTS · Delayed Price · Currency is USD
5.92
+1.32 (28.70%)
Jul 25, 2025, 3:23 PM EDT
Propanc Biopharma Market Cap
Propanc Biopharma has a market cap or net worth of $68.74 million as of July 25, 2025. Its market cap has increased by 71,937.46% in one year.
Market Cap
68.74M
Enterprise Value
69.94M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$5.92
Market Cap Chart
Since February 14, 2022, Propanc Biopharma's market cap has increased from 1.26M to 68.74M, an increase of 5,366.61%. That is a compound annual growth rate of 219.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 68.74M | 41,355.64% |
| Dec 31, 2024 | 165.82K | -50.41% |
| Dec 29, 2023 | 334.41K | -33.52% |
| Dec 30, 2022 | 502.99K | -60.00% |
| Feb 14, 2022 | 1.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.81B |
| Veradigm | 789.71M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.35M |
| Glass House Brands | 435.78M |
| CytoDyn | 367.24M |
| Northwest Biotherapeutics | 367.14M |